1. Inicio
  2. Proyectos y Estudios Clínicos
  3. halt-RONIN - Discovering chronic inflammation biomarkers that define key stages in the Healthy-to-NASH (non-alcoholic steatohepatitis) transition to inform early prevention and treatment strategies

halt-RONIN - Discovering chronic inflammation biomarkers that define key stages in the Healthy-to-NASH (non-alcoholic steatohepatitis) transition to inform early prevention and treatment strategies

Datos básicos

Código:
EU22/16
Dotación:
438.886,25 €
Año Inicial:
2022
Año final:
2026
PROYECTO Investigación cooperativa EUROPEA Subvención

Objetivos del proyecto

Non-alcoholic fatty liver disease (NAFLD) is a multifactorial chronic inflammatory disease that is prevalent in 1 of 4 individuals with a significant personal, socioeconomic and healthcare burden, especially at the later, more severe inflammatory stage of disease - nonalcoholic steatohepatitis (NASH). Despite the severe negative impact of the disease on society, NAFLD remains difficult to diagnose and treat. Hence, Halt-RONIN aims to uncover the early triggers of disease initiation and complex mechanistic drivers of disease progression by implementing a systems biology approach with integrative disease modelling resulting in opportunities for the improvement of the existing detection methods, providing a blueprint to inform personalized intervention strategies and drug discovery for NAFLD.

Unidades de investigación

Documentos

  • No hay documentos

Participantes

Financiadores

COMISIÓN EUROPEA

Compartir